 GABA Agents
"GABA Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances used for their pharmacological actions on GABAergic systems. GABAergic agents include agonists, antagonists, degradation or uptake inhibitors, depleters, precursors, and modulators of receptor function.
| Descriptor ID |
D018682
|
| MeSH Number(s) |
D27.505.519.625.240 D27.505.696.577.240
|
| Concept/Terms |
GABA Agents- GABA Agents
- Agents, GABA
- gamma-Aminobutyric Acid Agents
- Acid Agents, gamma-Aminobutyric
- Agents, gamma-Aminobutyric Acid
- gamma Aminobutyric Acid Agents
- GABAergic Agent
- Agent, GABAergic
- GABAergic Agents
- Agents, GABAergic
GABA Effect- GABA Effect
- Effect, GABA
- GABAergic Effect
- Effect, GABAergic
- GABAergic Effects
- Effects, GABAergic
- GABA Effects
- Effects, GABA
|
Below are MeSH descriptors whose meaning is more general than "GABA Agents".
Below are MeSH descriptors whose meaning is more specific than "GABA Agents".
This graph shows the total number of publications written about "GABA Agents" by people in this website by year, and whether "GABA Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 1 | 0 | 1 | | 2015 | 0 | 1 | 1 | | 2017 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "GABA Agents" by people in Profiles.
-
Block A, Ahmed MM, Rueda N, Hernandez MC, Martinez-Cu? C, Gardiner KJ. The GABAAa5-selective Modulator, RO4938581, Rescues Protein Anomalies in the Ts65Dn Mouse Model of Down Syndrome. Neuroscience. 2018 02 21; 372:192-212.
-
Martin BS, Martinez-Botella G, Loya CM, Salituro FG, Robichaud AJ, Huntsman MM, Ackley MA, Doherty JJ, Corbin JG. Rescue of deficient amygdala tonic ?-aminobutyric acidergic currents in the Fmr-/y mouse model of fragile X syndrome by a novel ?-aminobutyric acid type A receptor-positive allosteric modulator. J Neurosci Res. 2016 Jun; 94(6):568-78.
-
Elkashef A, Kahn R, Yu E, Iturriaga E, Li SH, Anderson A, Chiang N, Ait-Daoud N, Weiss D, McSherry F, Serpi T, Rawson R, Hrymoc M, Weis D, McCann M, Pham T, Stock C, Dickinson R, Campbell J, Gorodetzky C, Haning W, Carlton B, Mawhinney J, Li MD, Johnson BA. Topiramate for the treatment of methamphetamine addiction: a multi-center placebo-controlled trial. Addiction. 2012 Jul; 107(7):1297-306.
-
Savic MM, Majumder S, Huang S, Edwankar RV, Furtm?ller R, Joksimovic S, Clayton T, Ramerstorfer J, Milinkovic MM, Roth BL, Sieghart W, Cook JM. Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats? Prog Neuropsychopharmacol Biol Psychiatry. 2010 Mar 17; 34(2):376-86.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|